PI3K/mTOR Pathway Alterations May Mediate PD-1/PD-L1 Blockade Resistance in Non-Small Cell Lung Cancer

被引：0

作者：

Shou, T. ^{[1
]}

Wu, X. ^{[2
]}

Shang, Y. ^{[3
]}

Gao, F. ^{[4
]}

Wang, W. ^{[5
]}

Zhang, Z. ^{[6
]}

Wang, B. ^{[7
]}

Wang, Y. ^{[8
]}

Shi, J. ^{[9
]}

Yao, M. ^{[9
]}

Wang, A. ^{[9
]}

Wang, K. ^{[9
]}

机构：

[1] First Peoples Hosp Yunnan Prov, Kunming, Yunnan, Peoples R China

[2] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China

[3] Hebei Univ, Affiliated Hosp, Baoding, Peoples R China

[4] Second Tumor Hosp Heilongjiang Prov, Harbin, Heilongjiang, Peoples R China

[5] Hunan Canc Hosp, Changsha, Hunan, Peoples R China

[6] Hangzhou Canc Hosp, Hangzhou, Zhejiang, Peoples R China

[7] Peking Univ, Hosp 1, Beijing, Peoples R China

[8] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China

[9] Origimed, Shanghai, Peoples R China

来源：

关键词：

PD-1; blockade; Resistance;

D O I：

10.1016/j.jtho.2017.09.1700

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.07-009

引用

页码：S2301 / S2301

页数：1